Merck (NYSE: MRK) announced the completion of its acquisition of Terns Pharmaceuticals (NASDAQ: TERN) for $53.00 per share in cash ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE